Tag Archives: COVID 19

Death, Stroke, and Hospitalization while Waiting for TAVR

Death, Stroke, and Hospitalization while Waiting for TAVR

The consequences of deferring transcatheter aortic valve replacement (TAVR) procedures because of the COVID 19 pandemic are piling up. Untreated severe aortic stenosis patients who had been scheduled for TAVR are seeing increased risk of all events, even mortality.  According to recent studies published in JAMA, deferring TAVR in patients with symptomatic aortic stenosis is

Manejo de los infartos durante la pandemia de Covid-19

Long-Term Cardiovascular Effects of COVID-19

In many places worldwide, the worst part of the pandemic is still to come. Meanwhile, in other areas, the number of cases is rising again. In this context, the long-term effects of COVID-19 are starting to show. Many believe this is not a current issue, but it will definitely be a problem in the future.

Manejo de los infartos durante la pandemia de Covid-19

LATAM: Information on the Impact of the Pandemic with a Focus on MI

There are several studies from all corners of the world (China, Europe, USA) presenting data on the impact of COVID19 on interventional cardiology in general, and on MI in particular. What is new about this study is that it presents data on LATAM and that it has been published in an international magazine.  Seldom do

Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic

The coronavirus pandemic has had a negative impact on the most pressing cardio and neurological emergencies, such as strokes or aortic dissection. These emergencies are normally treated in high complexity centers, which is why it is relatively simple to analyze the number of transfers before and after the pandemic.  For some time, care centers have

Recomendaciones de la ACC con el nuevo coronavirus

When and How Could Dexamethasone Be Useful in a COVID-19 Infection?

More details have emerged on the group of COVID-19 patients who received dexamethasone in the RECOVERY trial. These data, published as a preliminary report in the New England Journal of Medicine (NEJM), suggest that dexamethasone could reduce mortality in cases when infection effects are mainly derived from immunopathological elements in patients requiring mechanical ventilation or

Coronavirus y corazón ¿Cómo deben prepararse los cardiólogos?

Rapid Drop of Antibodies in Mild COVID-19 patients

A fast drop in COVID-19 antibodies in mild patients triggers the alarm for protection against the new virus. This decrease, observed within the first 90 days after contagion, might slow down over time. However, it calls for caution when it comes to the feeling of “protection” in recovered patients, vaccine immunization at long-term, and ultimately

Trombólisis local en tromboembolismo pulmonar

COVID-19 PE: Nontraditional Risk Factors?

Risk factors for pulmonary embolism (PE) among patients with the new coronavirus are different from those traditionally observed. A French study recently published in Eur Heart J showed those new risk factors, and also that the risk of PE is reduced by the use of anticoagulant agents, just like in patients with conventional risk factors.

Revascularización del SCACEST | Tiempos y Modos de Revascularización en Época de COVID 19

Webinar SOLACI | NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era

Watch again our Webinar on “NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era” on our Youtube account.     We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Coronavirus y corazón ¿Cómo deben prepararse los cardiólogos?

Vasculitis, Thrombosis and Angiogenesis: Covid-19´s Unique Patters

In this small, yet interesting series, we observe angiogenesis could differentiate pulmonary physiopathology by Covid-19 vs. from viral infections of similar severity (such as influenza). Being quite small, we can hardly consider it universal, or whether it could have clinical impact. Meanwhile, we keep learning about the new virus.  Progressive respiratory failure is the main

Manejo de los infartos durante la pandemia de Covid-19

European Association of Percutaneous Cardiovascular Interventions Position Statement During the Pandemic

This document emerges from the assembly of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Acute Cardiovascular Care Association (ACVC). Both associations gathered their most prominent experts, including people who worked in the European areas most affected by COVID-19. Their aim was to modify diagnostic and therapeutic algorithms to adapt the evidence collected

Top